Matthew Sykes

Stock Analyst at Goldman Sachs

(4.02)
# 585
Out of 5,042 analysts
210
Total ratings
55.48%
Success rate
10.14%
Average return

Stocks Rated by Matthew Sykes

Fortrea Holdings
May 14, 2025
Maintains: Neutral
Price Target: $7$5
Current: $11.30
Upside: -55.75%
Cytek Biosciences
May 12, 2025
Maintains: Sell
Price Target: $3.5$3
Current: $4.26
Upside: -29.58%
10x Genomics
May 12, 2025
Maintains: Sell
Price Target: $7.5$6.5
Current: $13.77
Upside: -52.80%
Bruker
May 8, 2025
Maintains: Neutral
Price Target: $50$45
Current: $39.00
Upside: +15.38%
Myriad Genetics
May 7, 2025
Maintains: Buy
Price Target: $14$8
Current: $8.15
Upside: -1.84%
Twist Bioscience
May 6, 2025
Maintains: Buy
Price Target: $55$48
Current: $34.11
Upside: +40.72%
Sotera Health Company
May 5, 2025
Upgrades: Buy
Price Target: $14$17
Current: $16.86
Upside: +0.83%
ICON Public Limited Company
May 2, 2025
Maintains: Neutral
Price Target: $180$160
Current: $178.11
Upside: -10.17%
NeoGenomics
Apr 30, 2025
Maintains: Buy
Price Target: $15$10
Current: $10.67
Upside: -6.28%
Revvity
Apr 29, 2025
Maintains: Buy
Price Target: $140$125
Current: $98.89
Upside: +26.40%
Downgrades: Neutral
Price Target: $23$14
Current: $15.40
Upside: -9.09%
Maintains: Buy
Price Target: $260$240
Current: $223.01
Upside: +7.62%
Maintains: Buy
Price Target: $34$26
Current: $14.97
Upside: +73.68%
Downgrades: Neutral
Price Target: $190$170
Current: $197.04
Upside: -13.72%
Maintains: Buy
Price Target: $49$56
Current: $72.15
Upside: -22.38%
Maintains: Neutral
Price Target: $70$80
Current: $128.87
Upside: -37.92%
Maintains: Neutral
Price Target: $1.75$1.5
Current: $2.02
Upside: -25.74%
Maintains: Buy
Price Target: $160$190
Current: $192.51
Upside: -1.30%
Downgrades: Sell
Price Target: $2.25$1.75
Current: $1.22
Upside: +43.44%
Downgrades: Sell
Price Target: $7$4.25
Current: $3.41
Upside: +24.63%
Downgrades: Neutral
Price Target: $38$37
Current: $36.73
Upside: +0.74%
Maintains: Buy
Price Target: $75$65
Current: $64.64
Upside: +0.56%
Maintains: Buy
Price Target: $280$250
Current: $220.52
Upside: +13.37%
Maintains: Buy
Price Target: $35$24
Current: $5.72
Upside: +319.58%
Maintains: Neutral
Price Target: $1,150$1,300
Current: $1,434.32
Upside: -9.36%
Maintains: Sell
Price Target: $32$12
Current: $13.57
Upside: -11.57%
Maintains: Buy
Price Target: $550$640
Current: $572.50
Upside: +11.79%
Maintains: Buy
Price Target: $128$145
Current: $148.03
Upside: -2.05%
Upgrades: Buy
Price Target: n/a
Current: $49.32
Upside: -